Gradient reduction following non-surgical septal reduction in hypertrophic obstructive cardiomyopathy is maintained over three month follow-up

被引：0
|
作者：
Knight, CJ [1 ]
Gunning, M [1 ]
Henein, M [1 ]
Vecht, R [1 ]
Sutton, R [1 ]
Gibson, DG [1 ]
Somerville, J [1 ]
Sigwart, U [1 ]
机构：
[1] ROYAL BROMPTON HOSP,LONDON SW3 6LY,ENGLAND
来源：
HEART | 1996年 / 75卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：235 / 235
页数：1
相关论文
共 50 条
  • [21] Long-term Clinical Follow-Up of Patients Undergoing Percutaneous Alcohol Septal Reduction for Symptomatic Obstructive Hypertrophic Cardiomyopathy
    de Cano, Silvia Fortunato
    Cano, Manuel Nicolas
    Costa, Jose de Ribamar, Jr.
    Pinheiro, Jairo Alves, Jr.
    de Mattos Barretto, Rodrigo Bellio
    de Souza Le Bihan, David Costa
    Abizaid, Alexandre
    Sousa, Amanda
    Eduardo Sousa, J.
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 88 (06) : 953 - 960
  • [22] Alcohol septal ablation for hypertrophic obstructive cardiomyopathy improves myocardial performance: A 24-month follow-up
    Veselka, J
    PROGRESS IN CORONARY ARTERY DISEASE, 2005, : 363 - 366
  • [23] Septal ablation for hypertrophic obstructive cardiomyopathy: An analysis of the patients with dissatisfactory reduction of the outflow gradient
    Faber, L
    Werlemann, B
    Krater, L
    Seggewiss, H
    Horstkotte, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 200A - 200A
  • [24] Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy
    Ruzyllo, W
    Chojnowska, L
    Demkow, M
    Witkowski, A
    Kusmierczyk-Droszcz, B
    Piotrowski, W
    Rausinska, L
    Karcz, M
    Malecka, L
    Rydlewska-Sadowska, W
    EUROPEAN HEART JOURNAL, 2000, 21 (09) : 770 - 777
  • [25] Tumor necrosis factor x is a potential mediator of pressure overload injury in patients with hypertrophic obstructive cardiomyopathy:: Effects of non-surgical septal reduction
    Torre-Amione, G
    Stetson, SS
    Youker, KA
    Lakkis, NM
    Spencer, WH
    Entman, ML
    Nagueh, SF
    CIRCULATION, 1999, 100 (18) : 128 - 128
  • [26] Follow-Up of Up to 25 Years After Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
    Veselka, Josef
    Tesar, David
    Topalo, Robert
    Hansvenclova, Eva
    Adlova, Radka
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (12) : 1556 - 1557
  • [27] Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
    Nagueh, SF
    Ommen, SR
    Lakkis, NM
    Nishimura, RA
    Killip, D
    Zoghbi, WA
    Schaff, HV
    Danielson, GK
    Quiñones, MA
    Tajik, AJ
    Spencer, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (02) : 200A - 201A
  • [28] Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
    Nagueh, SF
    Ommen, SR
    Lakkis, NM
    Killip, D
    Zoghbi, WA
    Schaff, HV
    Danielson, GK
    Quiñones, MA
    Tajik, AJ
    Spencer, WH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (06) : 1701 - 1706
  • [29] Long-term follow-up in hypertrophic obstructive cardiomyopathy after septal myectomy
    Schönbeck, MH
    Brunner-La Rocca, HP
    Vogt, PR
    Lachat, M
    Jenni, R
    Hess, OM
    Turina, MI
    ANNALS OF THORACIC SURGERY, 1998, 65 (05): : 1207 - 1214
  • [30] Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions
    Qin, JX
    Shiota, T
    Lever, HM
    Asher, CR
    Popovic, ZB
    Greenberg, NL
    Agler, DA
    Drinko, JK
    Smedira, NG
    Tuzcu, EM
    Lytle, BW
    Thomas, JD
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (02): : 171 - 175
12345